Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity
Authors
Keywords
-
Journal
eLife
Volume 10, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2021-09-02
DOI
10.7554/elife.69032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clarifying role of time series data in the population genetics of HIV
- (2021) Alison F. Feder et al. PLoS Genetics
- Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
- (2020) Julia L. Marcus et al. JAMA Network Open
- Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
- (2019) Natasha Strydom et al. PLOS MEDICINE
- Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
- (2019) Corbin G. Thompson et al. Science Translational Medicine
- The need for mathematical modelling of spatial drug distribution within the brain
- (2019) Esmée Vendel et al. Fluids and Barriers of the CNS
- Evolutionary Dynamics in Structured Populations Under Strong Population Genetic Forces
- (2019) Alison F. Feder et al. G3-Genes Genomes Genetics
- Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel
- (2018) Huldrych F Günthard et al. CLINICAL INFECTIOUS DISEASES
- Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016
- (2018) G. Rocheleau et al. CLINICAL MICROBIOLOGY AND INFECTION
- The global burden of HIV-1 drug resistance in the past 20 years
- (2018) Maurizio Zazzi et al. PeerJ
- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- Spatiotemporal microbial evolution on antibiotic landscapes
- (2016) M. Baym et al. SCIENCE
- More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
- (2016) Alison F Feder et al. eLife
- Mass Spectrometry Imaging Reveals Heterogeneous Efavirenz Distribution within Putative HIV Reservoirs
- (2015) Corbin G. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future
- (2015) Alice Tseng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations
- (2015) Eric H. Decloedt et al. CLINICAL PHARMACOKINETICS
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
- (2015) Hyo-eun C Bhang et al. NATURE MEDICINE
- Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
- (2015) Stefany Moreno-Gamez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy
- (2015) Feng Fu et al. PLoS Computational Biology
- Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up
- (2014) Frederick J. Lee et al. PLoS One
- Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
- (2014) Courtney V. Fletcher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs
- (2014) Yoshiki Koizumi et al. Theoretical Biology and Medical Modelling
- Loss and Recovery of Genetic Diversity in Adapting Populations of HIV
- (2014) Pleuni S. Pennings et al. PLoS Genetics
- A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns
- (2013) Anna Bershteyn et al. BMC Systems Biology
- Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV
- (2012) D. Cadosch et al. Journal of the Royal Society Interface
- Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind
- (2012) David Basanta et al. MOLECULAR PHARMACEUTICS
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
- (2012) Daniel I S Rosenbloom et al. NATURE MEDICINE
- A quantitative basis for antiretroviral therapy for HIV-1 infection
- (2012) Benjamin L Jilek et al. NATURE MEDICINE
- On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient
- (2012) R. Hermsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Standing Genetic Variation and the Evolution of Drug Resistance in HIV
- (2012) Pleuni Simone Pennings PLoS Computational Biology
- Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract
- (2011) Laura J Else et al. ANTIVIRAL THERAPY
- Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes
- (2011) Vivek Jain et al. JOURNAL OF INFECTIOUS DISEASES
- Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance
- (2011) M. E. S. Sampah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
- (2010) M. E. Abram et al. JOURNAL OF VIROLOGY
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
- (2010) Julio SG Montaner et al. LANCET
- Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South Africa
- (2009) Christopher J. Hoffmann et al. CLINICAL INFECTIOUS DISEASES
- Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
- (2009) Caroline Bazzoli et al. CLINICAL PHARMACOKINETICS
- Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes
- (2009) Birgitte B. Simen et al. JOURNAL OF INFECTIOUS DISEASES
- Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen
- (2008) Zoe Fox et al. AIDS
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- Differential Extracellular and Intracellular Concentrations of Zidovudine and Lamivudine in Semen and Plasma of HIV-1-Infected Men
- (2008) Julie B Dumond et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine
- (2008) R. Paredes et al. JOURNAL OF VIROLOGY
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started